Accessibility List
Sykes And Ray Equities Open An Account Button
SRE India Mobile Trading App Download Promotion
Sykes And Ray Equities India Start SIP Investment Visual
Sykes And Ray Equities India Start Trading Online Visual

Markets

  1. Home
Market Nav

TORRENT PHARMACEUTICALS LTD.

  • NSE CodeTORNTPHARMEQ
  • BSE Code500420
  • ISININE685A01028
  • IndustryPharmaceuticals

Company Information

Management

Samir Mehta

Executive Chairman

Incorporation Year

15/07/1972

Registered Address

Registered Office : Avirat, Thaltej Shilaj Road,
Ahmedabad, Gujarat - 380059
Tel: 079-26599000
Fax: 079-26582100

Registrar Office

KFIN Technologies Pvt. Ltd.
Selenium Tower B, Plot No. 31-32,Gachibowli, Financial District, Nanakramguda,Serilingampally Man
Hyderabad,500032,Telangana
Tel: 040-67161500
Fax: 23420814

Email

[email protected]

Website

http://www.torrentpharma.com

Listing

BSE, BSE, MCXSX, NSE

Corporate News

Torrent Pharma. has submitted to BSE the Shareholdin...

21-Jul-2026|12:40PM

As of July 2026, 60.78% is owned by Indian Promoters and 39.22% by Public.

Torrent Pharma. has submitted to BSE the Shareholdin...

20-Jul-2026|7:40PM

As of June 2026, 68.31% is owned by Indian Promoters and 31.69% by Public.

Torrent Pharma. - General Updates

20-Jul-2026|12:44PM

Torrent Pharmaceuticals Limited has informed the Exchange about General Upd

Torrent Pharma. - Allotment Of 4,19,22,416 Fully Pai...

20-Jul-2026|12:43PM

Allotment of Equity shares of the Company to eligible shareholders of J B C

More

Share Holding Pattern

Peer Comparison

Company NamePrice (₹)Market Cap(₹ Cr)
Aarey Drug77.20218.90
Aarti Drug410.003,742.07
Aarti Pharma659.805,983.05
Abbott India28,690.0060,964.25
Accent Micro505.951,213.72
More

MF Holding

Scheme NameValue
(₹ Cr)		Holding (%)
HDFC La..1469.613.77
Axis La..324.641.05
UTI Fle..320.401.40
UTI Nif..223.332.61
Axis La..190.431.16
More

Board Meetings

DatePurpose
30/07/2026Quarterly Results
22/05/2026Audited Results, Divide..
13/02/2026Quarterly Results &..
05/01/2026Others
07/11/2025Quarterly Results
More